Welcome to the Hologic Investor Relations page


Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems and surgical products. The Company’s core business units focus on diagnostics, breast health, GYN surgical, and skeletal health. With a unified suite of technologies and a robust research and development program, Hologic is dedicated to The Science of Sure.

The Company's Common Stock is listed on the Nasdaq Global Select Market under the trading symbol "HOLX".


Monday, December 1, 2014
Hologic Enters the Viral Load Market with CE Mark Certification for the Aptima HIV-1 Viral Load Test
Read Release


Thursday, November 6, 2014
President and CEO Steve MacMillan on CNBC Squawk Box
Watch Video


Wednesday, November 5, 2014
Hologic Announces Fourth Quarter Fiscal 2014 Operating Results
Read Release
View Presentation


Friday, October 31, 2014
The Centers for Medicare and Medicaid Services Issues Ruling on 2015 Reimbursement Rates
Read Release


Wednesday, October 1, 2014
It's "Genius": Hologic Launches New Consumer Awareness Campaign for Its Breakthrough 3D Mammography Technology
Read Release


Comments? Please fill out our Feedback Form and let us know how you like our Investor website.